| GUANGZHOU BAIYUNSHAN PHARMACEUTICAL |
| China |
| Gesundheit |
| CNE100000387 / A0M4X5 |
| GU5 (Frankfurt) |
| FRA:GU5, ETR:GU5, GU5:GR |
| - |
| https://www.gybys.com.cn/ |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. is a key player in the pharmaceutical industry, primarily involved in the research, development, manufacturing, and distribution of an extensive range of healthcare products. Its product portfoli..
>Volltext.. |
| 4498.68 Mio. EUR |
| 4398.78 Mio. EUR |
| 9353.03 Mio. EUR |
| 484.8 Mio. EUR |
| 356.77 Mio. EUR |
| 0.22 EUR |
| 2564.51 Mio. EUR |
| 1851.87 Mio. EUR |
| 31.77 Mio. EUR |
| 0.61 |
| -9.08% |
| -8.48% |
| 0.1 EUR |
| 5.16% |
| 5.77% |
| 29.08.25 - 0.048582558€ 16.06.25 - 0.048173927€ >weitere anzeigen... |
| - |
| GUANGZHOU BAIYUNSHAN, GYBYS |
| 05.04.26 |
|
||||
|
||||
|